Office pulse pressure (PP) has been found to be independently associated with cardiovascular morbidity and mortality. While there is evidence that 24 h blood pressure (BP) is a better marker of the cardiovascular complications of hypertension than office BP, this information is still lacking in regard to PP. The aim of the present study was, therefore, to evaluate possible differences between office and 24 h PP in their relationship with cardiovascular risk profile. This cross-sectional study was performed in a group of 175 (104 M, 71 F) hypertensives (43 never treated before the study) free of clinical evidence of target organ disease. BP was measured at rest and during 24 h monitoring; cardiac structure and function was studied by ultrasounds; biochemical analyses were performed to evaluate some parameters of lipid and carbohydrate metabolism.
Introduction
Pulse pressure (PP)Fthe difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP)Fhas been extensively investigated in the last few years. [1] [2] [3] [4] [5] Since the main determinant of PP is arterial stiffening, 1,2 PP increases with age, which induces a progressive rise in SBP and a fall in DBP due to the decrease of the elastic capacity of the aorta. 1, 6, 7 PP is an independent predictor of heart failure in the elderly. 8 Moreover, it has been found to be a powerful predictor of cardiovascular morbidity and mortality. [9] [10] [11] [12] Verdecchia first cast doubts that office PP, like office SBP and DBP, could not be representative of the usual PP and, therefore, that ambulatory PP might be a more suitable predictor of cardiovascular morbidity and mortality. 13 The aim of the present investigation was to compare in a sample of noncomplicated hypertensives, the power of office and ambulatory PP in detecting patients at higher risk of developing cardiovascular complications of hypertensive disease.
Patients and methods
The study was performed in 175 hypertensive outpatients. Some of them (n ¼ 43) had never received any antihypertensive treatment before entering the study, while others had been on dietary or drug therapy previously. In order to avoid interference from previous treatment, all patients were followed for a run-in of 1 month without any treatment before collecting data. Exclusion criteria were: (a) biochemical or instrumental evidence of secondary hypertension, (b) total cholesterol 47.76 mmol/l and/or triglycerides 43.39 mmol/l, (c) fasting serum glucose 46.94 mmol/l, (d) evidence of cardiovascular disease, (e) evidence of other chronic diseases such as liver cirrhosis or renal failure, and (f) pregnancy or lactation.
After giving their informed consent to participate in the study, patients entered the run-in, in which their blood pressure at rest was measured three times at two-week intervals. At the end of the run-in, they underwent the following measurements:
* Height and weight, using a platform beam-scale (Seca 760); body mass index (BMI) was calculated as weight to squared height ratio (kg/m 2 ). * Office blood pressure (BP), using an automatic sphygmomanometer (Sentron, Bard Biomedical Division, C.R.Bard, Inc, Lombard, IL, USA); two BP readings were recorded with patients in the sitting position for at least 5 min, between 09.00 and 11.00 in the morning; the average of the two readings was considered as the measurement for that visit. * Twenty-four hour ambulatory blood pressure monitoring (ABPM), by Spacelabs Inc 90207 (Redmond Washington, USA), during a normal working day. The monitor was fitted on in the morning, between 10h 00 and 12h 00. Subjects were asked to perform their normal daily activities and to consume their habitual diet. After calibration, the monitor was programmed to record BP and heart rate (HR) at 15-min intervals during the subjects' waking hours and at 20-min intervals during their usual sleeping hours. Subjects were instructed to keep their arms still during recordings. For the analysis of the data, the 24-h measurements were divided into waking (07h 00-10h 45) and sleeping (23h 00-6h 40) periods. The 24-h record was acceptable if more than 80% of the scheduled readings were available. Patients also filled in a 24-h diary to report daily activities and rest, including the sleeping period. * Laboratory assessment of fasting serum glucose (FBG), total serum cholesterol (chol), triglycerides (Tg), and HDL-cholesterol; blood samples were drawn at 08h 30, after an overnight fast. Cholesterol content in the low-density lipoproteins (LDL chol) was calculated by the Friedewald formula 14 as follows:
* Peripheral insulin sensitivity was evaluated by homeostasis model assessment (HOMA), 15 according to the following formula:
HOMA ¼ Serum insulin Ã Fasting serum glucose=22:5:
* Two-dimensionally targeted M-mode echocardiograms were performed by an expert sonographer using a commercially available echocardiograph (AU3 Partner ESAOTE Biomedica, Florence, Italy), connected to a 2.5-3.5 MHz annular-array transducer and tape-recorded on videotapes. A standard protocol was used to perform echocardiograms; strip-chart tracings of all patients were obtained at 50 mm/s velocity and examined by experienced investigators, blinded to clinical information, using a graphic tablet and a pointer device interfaced with a PC computer, using dedicated software. 16 Left ventricular end-diastolic (LVIDD) and end-systolic (LVISD) internal diameters, posterior wall (PWT) and septal thicknesses (IVST) were measured according to the recommendations of the American Society of Echocardiography. 17 A second set of measurements was also taken according to Penn convention criteria, to calculate left ventricular mass (LVM). 18 To take into account body size, LVM was normalized for body height to the power 2.7, (LVMi) an indexation that has been shown also to detect deviations from normality in obese individuals. 19 The presence of LV hypertrophy was defined by an LVMi451 g/m 2.7 , a prognostically validated partition value. 20 Relative wall thickness (RWT), an index of LV geometric pattern, was measured at end diastole, as 2 Ã PWT/LVIDD. The aortic root (AR) was measured according to the recommendations of the American Society of Echocardiography. Left atrium (LA) was measured from trailing edge to leading edge, at endsystole.
Immediately after M-mode recordings, a pulsed Doppler echocardiography was performed. Transmitral flow velocity waveforms were obtained from apical in the four and five chamber views with sample volume placed at the level of the mitral annulus and at the tip of mitral valve leaflets, and the angle between the Doppler beam and mitral annulus was kept at 90 7 101, as previously described. 21 The peaks of the early diastolic velocity wave (E) and the late diastolic wave (A) were measured in m/s and their E/A ratio was calculated.
Statistical analysis
Data were stored and analysed by the SPSS statistical package. Data are expressed as mean 7 -standard deviation (M 7 s.d.). Continuous variables were compared by one-way analysis of variance with Tukey's multiple comparisons, and noncontinuous ones by the w 2 test. The strength of correlation between continuous variables was tested by the Pearson linear correlation, partial correlation and stepwise multiple regression analysis. A P value of 0.05 was considered significant.
Results
In total, 75 patients (104 M, 71 F), age range 45 7 74 years, with arterial hypertension entered the study group. They were divided into tertiles according to clinic or 24 h PP. The first tertile comprised patients with clinic and 24 h PP below 50 and 46 mmHg, respectively, the second those with clinic and 24 h PP between 50-64, and 46-61 mmHg, respectively, the third patients with clinic and 24 h PP above 64 and 61 mmHg, respectively. Despite a trend to increased age in the highest tertile of PP, no significant difference was detected in age, sex distribution and BMI. Characteristics of the patients are shown in Table 1 . Tertiles only differed for clinic and 24 h SBP and for clinic DBP (Figure 1) . Age was significantly related to clinic PP (r ¼ 0.224, Po0.005) and 24 h PP (r ¼ 0.311, Po0.001). In regard to biochemical parameters, serum cholesterol and triglycerides were similar in the three tertiles of PP (Table 1) ; HOMA, on the other hand, was significantly higher in the last tertile (Figure 2) . Moreover, clinic PP was significantly related to both HOMA (r ¼ 0.454, Po0.01) and serum insulin (r ¼ 0.437, Po0.02).
For cardiac structure, IVST and PWT of the left ventricle and, therefore, left ventricular mass index and RWT significantly increased from the first to the last tertile of PP ( Table 2) . Prevalence of left ventricular hypertrophy was 33, 38 and 50% respectively, (P ¼ 0.05) for tertiles of clinic PP and 23, 42 and 55% (P ¼ 0.05) for tertiles of 24 h PP, respectively. A close relationship between clinic and 24 h PP and the above-mentioned echographic parameters of the heart were observed (Table 3) . Stepwise multiple regression analysis was, therefore, performed including as dependent variables LVM or HOMA, and as independent variables age, BMI, SBP, DBP or PP, clinic or during 24-h monitoring. Obviously, BP parameters were included separately in the regression equation. We found that SBP and PP (clinic and during 24-h monitoring), but not DBP, were equally able to explain LVM variability (about 7%), entering as first variable followed by BMI but not by age. When HOMA was studied, PP was able to predict much better than SBP its variability (about 40%).
In regard to noninvasively determined parameters of diastolic function, tertiles differed for the A wave, with no difference in the E wave ( Table 2) .
Discussion
The present clinic study aimed at evaluating the role of PP in giving additional information regarding cardiovascular risk profile of hypertensive patients and, consequently, at comparing the power of office PP with that of ambulatory PP.
The main results of the present study indicate that PP is able to detect hypertensives with a cluster of IVST (mm) 10.6 7 1.5 11.5 7 1.7 11.8 7 1.5 *** cardiovascular risk factors, in particular a significant decrease in peripheral insulin sensitivity and a worse heart condition characterised by high prevalence of left ventricular hypertrophy and initial impairment of diastolic function. It has been shown that for any given aortic flow, total arterial compliance and total arterial resistance are sufficient to accurately describe systolic and diastolic pressure.
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Since arterial stiffening progressively develops with age, it appears obvious that PP significantly increases in the elderly. The present study has the peculiarity that groups of PP were not significantly different in age, thus excluding any interference from this powerful confounder. The increase in LVM is not a novel finding but confirmatory of previous observations. [23] [24] [25] This is in agreement with studies showing that arterial stiffness is strongly correlated with left ventricular hypertrophy. 26, 27 However, in the present study SBP, both clinic and during 24-h monitoring, was also able to detect hypertensives with increased LVM, in a way very similar to that of PP. We have also found that these patients have an early impairment of diastolic function, in particular of diastolic filling, as suggested by the increase of the late diastolic wave (A wave). This is not surprising since it has already been shown that altered peripheral insulin sensitivity is associated with impairment of diastolic function in patients with hypertension and is present in patients with diabetes or impaired glucose tolerance even without concomitant hypertension. [28] [29] [30] [31] The association of increased PP with altered metabolic profile of patients as, on the other hand, not been described previously. In our middle-aged patients, we detected that peripheral insulin tissue sensitivity was altered in those with increased PP, despite the lack of difference in body weight. In this regard SBP was a less powerful predictor than PP. Among the many different methods used to determine insulin sensitivity, the euglycaemic clamp technique is currently the best available tool; 32 HOMA, however, has been shown to satisfactorily correlate with it. 15 The last two findings are not the sole elements of novelty in this study. In fact, we have also shown that office PP and ambulatory PP are similarly effective in detecting patients with worse cardiovascular risk profile. This observation extends the findings by Verdecchia et al 13 on the relationship between PP and cardiovascular risk.
In conclusion, our findings support the hypothesis that the simple evaluation of PP, both office and 24 h, is able to segregate patients with a high coronary risk profile. Because most of these characteristics are also present in the plurimetabolic syndrome, 33 it should be interesting to verify in these patients whether increased PP may be a more suitable marker of the syndrome than blood pressure itself. Abbreviations: see Table 2 .
